September 5, 2013
Molecular Biomarkers to Inform Adjuvant Therapy for Lynch Syndrome
By AJ Montpetit
The most common hereditary colon cancer disorder, Lynch syndrome, increases the risk of colorectal cancer (CRC) and are usually caused by germline mutations in 1 of 4 mismatch repair (MMR) genes: MLH1, MSH2, MSH6 and PMS2. Identifying people who are at risk is important for their care, as well as the care of members of […]
Tags: biomarker, biomarkers, cancer, colorectal cancer, Genetics, genome, genomics, individualized medicine, lynch syndrome, molecular biomarkers